Particle engineering company Nanoform has announced that AstraZeneca is performing an evaluation of Nanoform's Controlled Expansion of Supercritical Solutions (CESS) technology "across a range of AstraZeneca’s proprietary pharmaceutical products." According to the Nanoform, its technology can produce particles as small as 10nm. Over the past few years, the … [Read more...] about Nanoform announces evaluation of its technology by AstraZeneca
Products and Services
H&T Presspart officially opens new injection molding facility
Device maker H&T Presspart has officially opened a new injection molding facility known as "Fenix" in Tarragona, Spain, the company said. The plant manufactures MDI actuators and other delivery device components. H&T Presspart Tarragona Managing Directors Thomas Portune and Dana Shears attended the ribbon cutting ceremony along with the president of the … [Read more...] about H&T Presspart officially opens new injection molding facility
HCmed Innovations to build R&D and production facilities in Wuxi International Life Science Innovation Park
Handheld nebulizer manufacturer HCmed Innovations announced that it has accepted an invitation to build an R&D center and production facility in the newly opened Wuxi International Life Science Innovation Park, which is anchored by AstraZeneca. HCMed's Deepro smart vibrating mesh nebulizers can be used for delivery of AstraZeneca's Pulmicort Respules, the company … [Read more...] about HCmed Innovations to build R&D and production facilities in Wuxi International Life Science Innovation Park
Hovione Technology partners with Kiel University on dry powder formulations
Hovione Technology has partnered with Kiel University Institute of Pharmacy on methods of dry powder formulation for delivery of high doses of antibiotics using Hovione Technology TwinMax and 8Shot DPIs, the company said. Areas of exploration will include techniques such as the use of soft pellets and nanocrystals for formulation of drugs such as clarithromycin and … [Read more...] about Hovione Technology partners with Kiel University on dry powder formulations
Meggle signs deal for distribution of pharmaceutical grade lactose in the US
LBB Specialties announced that it has signed a strategic partnership deal with Meggle for distribution of Meggle's pharmaceutical lactose excipients, including lactose for inhalation formulations, in the United States through LBB's Charkit Chemical and American International Chemical (AIC) subsidiaries. Charkit Chemical President Jay Lang said that "representing … [Read more...] about Meggle signs deal for distribution of pharmaceutical grade lactose in the US
Adherium announces deal with Summatix
Inhaler monitoring company Adherium said that it has signed a deal with Summatix (formerly Charm Informatics) to allow data from Adherium's Hailie connected inhaler sensors to be accessed through the Summatix medical data platform. Adherium also announced the launch of a new Hailie app for patients and an updated platform for clinicians. Adherium received OTC … [Read more...] about Adherium announces deal with Summatix
Proveris Scientific adds to its Americas and Asia Pacific customer support team
Proveris Scientific has announced an expansion of its Americas and Asia Pacific customer service support team with the hire of Doug Mann as a Field Service Engineer. The company also recently added Stephen McDonald to its European customer support team. Mann, who most recently provided field support at TTP LabTech, joins Senior Field Service Engineer Kevin O'Keefe … [Read more...] about Proveris Scientific adds to its Americas and Asia Pacific customer support team
Merxin says FDA deems its MRX001 blister multidose DPI appropriate for generic Advair
According to generic inhalation device developer Merxin, the FDA has reviewed data for the company's MRX001 blister multidose DPI and suggested that the agency would accept the MRX001 as an AB rated substitutable version of Diskus. The company shared this quote from the FDA's response: “After reviewing your controlled correspondence submitted on May 3, 2019, the … [Read more...] about Merxin says FDA deems its MRX001 blister multidose DPI appropriate for generic Advair
Nemera acquires Insight Product Development
Device developer and manufacturer Nemera has announced its acquisition of Insight Product Development, which will become the US office of Nemera's “Insight Innovation Center.” The company's other design center office is located in La Verpillière, France. Insight's capabilities include early stage development of DPIs, MDIs, and connected devices. According to Nemera, … [Read more...] about Nemera acquires Insight Product Development
ISAB gets contract for nebulizer feasibility study
Inhalation Sciences (ISAB) has announced that "a leading European inhaled pharmaceutical developer" has contracted with the company for a feasibility study using ISAB's PreciseInhale aerosol generator with new nebulizer capabilities. The feasibility study is the first to use the nebulizer feature for the PreciseInhale system, which launched in February 2019, the … [Read more...] about ISAB gets contract for nebulizer feasibility study